Trwa ładowanie...
Notowania

SPH report for June 2022

“Sopharma” AD (the Company) notifies that for June 2022 the Company recorded an increase in sales of 83% compared to the same month of the previous year, incl. 39% increase in domestic sales and 109% increase in export sales.
For the six months since the beginning of the year the revenues from sales of products increase by 37%, incl. 35% increase of sales for the domestic market and 38% increase in export sales.

Załączniki

Inne komunikaty